FDA Approved: LOTEMAX — Original Application (Bausch & Lomb Incorporated)

View source ↗

Summary

FDA approved Lotemax (loteprednol etabonate) ophthalmic suspension under NDA 202872 for the treatment of postoperative ocular inflammation and pain following ey…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation
• Postoperative Ocular Inflammation and Pain

Drugs mentioned

• Lotemax (Loteprednol etabonate)

Snippet

ORIG AP for LOTEMAX (LOTEPREDNOL ETABONATE)